Riskpilot← Back to searchSign inGet full accessOmnidoc AB
ABActiveOrg 5569681751Bergsgatan 13General medical practice activities · NACE 8621Est. 20140 employees
Revenue 2024
SEK 8K
-50% vs 2023
EBITDA margin
-438.8%
-17% vs 2023
Equity ratio
91.7%
Financial strength
Net profit 2024
SEK -32K
-15% vs 2023
| Revenue | SEK 8K | -50% |
| EBITDA | SEK -33K | -17% |
| Net profit | SEK -32K | -15% |
| Total assets | SEK 85K | -36% |
| Equity | SEK 78K | -35% |
| Employees | 0 | — |
Legal name
Omnidoc AB
Org number
5569681751
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
9 april 2014
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för företagets verksamhet är i huvudsak att bedriva medicinsk konsult-, kurs-, undervisning- och utvecklingsverksamhet. Även friskvård samt förvaltning av kapital och fastigheter och inom ovan nämnda områden, därmed förenlig verksamhet.
Address
Bergsgatan 13
Phone
+46762119976
Email
f.hallgren@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 38 | 136 | 44 | 15 | 8 |
| Staff expenses | — | — | −7 | −5 | −5 |
| EBITDA | −4 | 81 | −9 | −28 | −33 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −4 | 81 | −9 | −28 | −33 |
| Net financials | — | — | — | 0 | 1 |
| Profit before tax | −4 | 80 | −9 | −28 | −32 |
| Tax | −0 | −17 | — | — | — |
| Net profit | −4 | 63 | −9 | −28 | −32 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 123 | 222 | 167 | 132 | 85 |
| Equity | 114 | 177 | 148 | 120 | 78 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 9 | 45 | 19 | 12 | 7 |
| Total debt | 9 | 45 | 19 | 12 | 7 |
EBITDA margin
-438.8%
This company
15.8%
Market median
-2877% vs market
20202024
Equity ratio
91.7%
This company
38.2%
Market median
+140% vs market
20202024
Return on equity
-41.5%
This company
18.4%
Market median
-326% vs market
20202024
Net profit margin
-431.3%
This company
8.1%
Market median
-5425% vs market
20202024
Asset turnover
0.09×
This company
1.12×
Market median
-92% vs market
20202024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PF Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Omnidoc AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Fredrik Hallgren | Chief Executive Officer | 0 companies |
| Olle Gustav Bjurström | Deputy Board Member | 0 companies |
| Jan Peter Folke Hallgren | Deputy Board Member | 0 companies |
| Anna Maria Hallgren | Deputy Board Member | 0 companies |